Megumi Okuyama
Osaka University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Megumi Okuyama.
Journal of Immunology | 2008
Hiroyuki Saiga; Junichi Nishimura; Hirotaka Kuwata; Megumi Okuyama; Sohkichi Matsumoto; Shintaro Sato; Makoto Matsumoto; Shizuo Akira; Yasunobu Yoshikai; Kenya Honda; Masahiro Yamamoto; Kiyoshi Takeda
Mycobacterium tuberculosis invades alveolar epithelial cells as well as macrophages. However, the role of alveolar epithelial cells in the host defense against M. tuberculosis remains unknown. In this study, we report that lipocalin 2 (Lcn2)-dependent inhibition of mycobacterial growth within epithelial cells is required for anti-mycobacterial innate immune responses. Lcn2 is secreted into the alveolar space by alveolar macrophages and epithelial cells during the early phase of respiratory mycobacterial infection. Lcn2 inhibits the in vitro growth of mycobacteria through sequestration of iron uptake. Lcn2-deficient mice are highly susceptible to intratracheal infection with M. tuberculosis. Histological analyses at the early phase of mycobacterial infection in Lcn2-deficient mice reveal increased numbers of mycobacteria in epithelial cell layers, but not in macrophages, in the lungs. Increased intracellular mycobacterial growth is observed in alveolar epithelial cells, but not in alveolar macrophages, from Lcn2-deficient mice. The inhibitory action of Lcn2 is blocked by the addition of endocytosis inhibitors, suggesting that internalization of Lcn2 into the epithelial cells is a prerequisite for the inhibition of intracellular mycobacterial growth. Taken together, these findings highlight a pivotal role for alveolar epithelial cells during mycobacterial infection, in which Lcn2 mediates anti-mycobacterial innate immune responses within the epithelial cells.
Journal of Experimental Medicine | 2011
Masahiro Yamamoto; Ji Su Ma; Christina Mueller; Naganori Kamiyama; Hiroyuki Saiga; Emi Kubo; Taishi Kimura; Toru Okamoto; Megumi Okuyama; Hisako Kayama; Kisaburo Nagamune; Seiji Takashima; Yoshiharu Matsuura; Dominique Soldati-Favre; Kiyoshi Takeda
Toxoplasma virulence factor ROP18 targets endoplasmic reticulum–bound transcription factor ATF6β in the host cell, leading to the detrimental loss of ATF6β through proteasome-dependent degradation.
Journal of Virology | 2013
Taishi Kimura; Hiroshi Katoh; Hisako Kayama; Hiroyuki Saiga; Megumi Okuyama; Toru Okamoto; Eiji Umemoto; Yoshiharu Matsuura; Masahiro Yamamoto; Kiyoshi Takeda
ABSTRACT The interferon-inducible protein with tetratricopeptide (IFIT) family proteins inhibit replication of some viruses by recognizing several types of RNAs, including 5′-triphosphate RNA and 5′ capped 2′-O unmethylated mRNA. However, it remains unclear how IFITs inhibit replication of some viruses through recognition of RNA. Here, we analyzed the mechanisms by which Ifit1 exerts antiviral responses. Replication of a Japanese encephalitis virus (JEV) 2′-O methyltransferase (MTase) mutant was markedly enhanced in mouse embryonic fibroblasts and macrophages lacking Ifit1. Ifit1 bound 5′-triphosphate RNA but more preferentially associated with 5′ capped 2′-O unmethylated mRNA. Ifit1 inhibited the translation of mRNA and thereby restricted the replication of JEV mutated in 2′-O MTase. Thus, Ifit1 inhibits replication of MTase-defective JEV by inhibiting mRNA translation through direct binding to mRNA 5′ structures.
Journal of Bacteriology | 2007
Tomoya Katsube; Sohkichi Matsumoto; Masaki Takatsuka; Megumi Okuyama; Yuriko Ozeki; Mariko Naito; Yukiko Nishiuchi; Nagatoshi Fujiwara; Mamiko Yoshimura; Takafumi Tsuboi; Motomi Torii; Nobuhide Oshitani; Tetsuo Arakawa; Kazuo Kobayashi
Bacteria coordinate assembly of the cell wall as well as synthesis of cellular components depending on the growth state. The mycobacterial cell wall is dominated by mycolic acids covalently linked to sugars, such as trehalose and arabinose, and is critical for pathogenesis of mycobacteria. Transfer of mycolic acids to sugars is necessary for cell wall biogenesis and is mediated by mycolyltransferases, which have been previously identified as three antigen 85 (Ag85) complex proteins. However, the regulation mechanism which links cell wall biogenesis and the growth state has not been elucidated. Here we found that a histone-like protein has a dual concentration-dependent regulatory effect on mycolyltransferase functions of the Ag85 complex through direct binding to both the Ag85 complex and the substrate, trehalose-6-monomycolate, in the cell wall. A histone-like protein-deficient Mycobacterium smegmatis strain has an unusual crenellated cell wall structure and exhibits impaired cessation of glycolipid biosynthesis in the growth-retarded phase. Furthermore, we found that artificial alteration of the amount of the extracellular histone-like protein and the Ag85 complex changes the growth rate of mycobacteria, perhaps due to impaired down-regulation of glycolipid biosynthesis. Our results demonstrate novel regulation of cell wall assembly which has an impact on bacterial growth.
Journal of Immunology | 2008
Junichi Nishimura; Hiroyuki Saiga; Shintaro Sato; Megumi Okuyama; Hisako Kayama; Hirotaka Kuwata; Sohkichi Matsumoto; Toshirou Nishida; Yoshiki Sawa; Shizuo Akira; Yasunobu Yoshikai; Masahiro Yamamoto; Kiyoshi Takeda
Secretory leukocyte protease inhibitor (SLPI) has multiple functions, including inhibition of protease activity, microbial growth, and inflammatory responses. In this study, we demonstrate that mouse SLPI is critically involved in innate host defense against pulmonary mycobacterial infection. During the early phase of respiratory infection with Mycobacterium bovis bacillus Calmette-Guérin, SLPI was produced by bronchial and alveolar epithelial cells, as well as alveolar macrophages, and secreted into the alveolar space. Recombinant mouse SLPI effectively inhibited in vitro growth of bacillus Calmette-Guérin and Mycobacterium tuberculosis through disruption of the mycobacterial cell wall structure. Each of the two whey acidic protein domains in SLPI was sufficient for inhibiting mycobacterial growth. Cationic residues within the whey acidic protein domains of SLPI were essential for disruption of mycobacterial cell walls. Mice lacking SLPI were highly susceptible to pulmonary infection with M. tuberculosis. Thus, mouse SLPI is an essential component of innate host defense against mycobacteria at the respiratory mucosal surface.
PLOS Pathogens | 2009
Hisako Kayama; Ritsuko Koga; Koji Atarashi; Megumi Okuyama; Taishi Kimura; Tak W. Mak; Satoshi Uematsu; Shizuo Akira; Hiroshi Takayanagi; Kenya Honda; Masahiro Yamamoto; Kiyoshi Takeda
Host defense against the intracellular protozoan parasite Trypanosoma cruzi depends on Toll-like receptor (TLR)-dependent innate immune responses. Recent studies also suggest the presence of TLR-independent responses to several microorganisms, such as viruses, bacteria, and fungi. However, the TLR-independent responses to protozoa remain unclear. Here, we demonstrate a novel TLR-independent innate response pathway to T. cruzi. Myd88 −/− Trif −/− mice lacking TLR signaling showed normal T. cruzi-induced Th1 responses and maturation of dendritic cells (DCs), despite high sensitivity to the infection. IFN-γ was normally induced in T. cruzi-infected Myd88 −/− Trif −/− innate immune cells, and further was responsible for the TLR-independent Th1 responses and DC maturation after T. cruzi infection. T. cruzi infection induced elevation of the intracellular Ca2+ level. Furthermore, T. cruzi-induced IFN-γ expression was blocked by inhibition of Ca2+ signaling. NFATc1, which plays a pivotal role in Ca2+ signaling in lymphocytes, was activated in T. cruzi-infected Myd88−/−Trif−/− innate immune cells. T. cruzi-infected Nfatc1 −/− fetal liver DCs were impaired in IFN-γ production and DC maturation. These results demonstrate that NFATc1 mediates TLR-independent innate immune responses in T. cruzi infection.
Immunity | 2012
Masahiro Yamamoto; Megumi Okuyama; Ji Su Ma; Taishi Kimura; Naganori Kamiyama; Hiroyuki Saiga; Jun Ohshima; Miwa Sasai; Hisako Kayama; Toru Okamoto; David C. S. Huang; Dominique Soldati-Favre; Kyoji Horie; Junji Takeda; Kiyoshi Takeda
Journal of Experimental Medicine | 2009
Masahiro Yamamoto; Daron M. Standley; Seiji Takashima; Hiroyuki Saiga; Megumi Okuyama; Hisako Kayama; Emi Kubo; Hiroshi Ito; Mutsumi Takaura; Tadashi Matsuda; Dominique Soldati-Favre; Kiyoshi Takeda
International Immunology | 2012
Hiroyuki Saiga; Shoko Kitada; Yosuke Shimada; Naganori Kamiyama; Megumi Okuyama; Masahiko Makino; Masahiro Yamamoto; Kiyoshi Takeda
Biochemical and Biophysical Research Communications | 2010
Megumi Okuyama; Hisako Kayama; Koji Atarashi; Hiroyuki Saiga; Taishi Kimura; Ari Waisman; Masahiro Yamamoto; Kiyoshi Takeda